Advertisement
Advertisement
Invacare Corporation (IVC)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.0000 |
| Open | 1.0300 |
| Bid | 0.9670 x 1100 |
| Ask | 0.9660 x 1300 |
| Day's Range | 0.9550 - 1.0800 |
| 52 Week Range | 0.8000 - 8.7300 |
| Volume | |
| Avg. Volume | 600,470 |
| Market Cap | 33.969M |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.5150 |
| Earnings Date | Feb 08, 2022 - Feb 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Apr 02, 2020 |
| 1y Target Est | 4.83 |
- Zacks
Invacare (IVC) Reports Q2 Loss, Lags Revenue Estimates
Invacare (IVC) delivered earnings and revenue surprises of -20.45% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Invacare Reports Results for Second Quarter 2022
ELYRIA, Ohio, August 08, 2022--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended June 30, 2022.
- Zacks
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Surpass Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of 12.79% and 2.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
